Pelthos Therapeutics Inc. ( PTHS) Q4 2025 Earnings Call March 19, 2026 8:00 AM EDT ...
Ipsen has joined the ranks of companies working on T cell receptor (TCR) therapies for cancer, paying $45 million upfront for rights to early-stage candidates developed by US biotech Marengo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results